ORGN Q4 2025 Earnings EPS Well Below Estimates as Company Continues PreRevenue Stage IVR Q1 2026 Earnings Slight EPS Miss Amid Stable Operating Environment DLPN Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Reaction CNP Q1 2026 Earnings EPS Misses Estimate by a Narrow Margin Stock Edges Higher AIM ImmunoTech Q1 2026 Earnings WiderthanExpected Loss on Absence of Revenue CAC Q1 2026 Earnings EPS Beats Estimates by Nearly 3 Amid Modest Stock Decline